18 October 2019 - Amzeeq is the first ever FDA approved topical form of minocycline.
Foamix Pharmaceuticals a specialty pharmaceutical company, today announced that the U.S. FDA has approved its novel Amzeeq (minocycline) 4% topical foam.
Amzeeq, formerly known as FMX101, is indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older and is the first topical minocycline to be approved by the FDA for any condition.